2020 Program Highlights
Take a look at some of the program highlights from IPVC 2020 and start preparing for an unforgettable 2021 Conference experience.
OPENING PLENARY AND INTRODUCTION TO IPVC
Tuesday, July 21
Welcome by the meeting co-chair
Silvia De Sanjose, USA (PATH, Director of Scale-up Project Reproductive Health Global Program)
Welcome by the IPVS President and meeting co-chair
Margaret Stanley, UK (University of Cambridge, Department of Pathology, Emeritus Professor of Epithelial Biology)
Immunology
Rafi Ahmed, USA (Emory Vaccine Center, Director)
IPVC PLENARY SESSION 2
Wednesday, July 22
Global control of Hepatitis B
Pierre Van Damme, Belgium (University of Antwerp, Faculty of Medicine and Health Sciences, Professor)
HPV Pathogenesis in Animal Models
Paul Lambert, USA (Carbone Cancer Center, Director of the McArdle Laboratory for Cancer Research, Virology Program Leader)
Immunotherapy: Progress in the clinic
Cornelis Melief, The Netherlands (ISA Pharmaceuticals, Chief Scientific Officer; Leiden University Medical Center, Emeritus Professor and Head of the Department of Immunohematology and Blood Transfusion)
Live Q&A
All speakers and chairs
IPVC PLENARY SESSION 3
Thursday, July 23
T cell dysfunction and implications for immunotherapy
Andrea Schietinger, USA (Memorial Sloan Kettering Cancer Center, Assistant Professor and Cancer Immunologist)
Laser ART and CRISPR approaches for viral elimination
Howard Gendelman, USA (Durham Research Center, Professor of Internal Medicine and Infectious Diseases)
DNA Methylation and Women’s Cancers
Martin Widschwendter, UK (University College London, Head of the Department of Women’s Cancer)
Live Q&A
All speakers and chairs
IPVC PLENARY SESSION 4
Friday, July 24
Resource-appropriate immunotherapeutic approaches to the elimination of cervical cancer
Corey Casper, USA (Infectious Disease Research Institute, Interim President and Chief Scientific Officer)
Use of Deep Learning into Cervical Cancer Screening
Mark Schiffman, USA (National Cancer Institute, Senior Investigator)
Oral Cancer Therapeutics
Robert Ferris, USA (UPMC Hillman Cancer Center, Director)
IPVC CLOSING PLENARY
Friday, July 24
Introduction
Margaret Stanley, UK (University of Cambridge, Department of Pathology, Emeritus Professor of Epithelial Biology)
Immunology HPV vaccines
Denise Galloway, USA (Fred Hutch; Pathogen-Associated Malignancies Integrated Research Center, Scientific Director)
Followed by:
Live Q&A with Denise Galloway
HPV, a personal view (Pre-recorded)
Xavier Bosch, Spain (Catalan Institute of Oncology (ICO), Honorary Consultant to the Cancer Epidemiology Research Program & Director of the e-oncologia at ICO)
Video message from Dr Adhanom Ghebreyesus, Director-General of the World Health Organization (Pre-recorded)
WHO’s Cervical Cancer Elimination Strategy
Princess Nothemba Simelela, Switzerland (Assistant Director-General/Special Adviser to DG, Strategic Programmatic Priorities)
IPVC 2021
Ann Burchell, Canada (Dept of Family and Community Medicine and MAP Centre for Urban Health Solutions, St Michael’s Hospital, Associate Professor)
Closing remarks
Silvia De Sanjose, USA (PATH, Director of Scale-up Project Reproductive Health Global Program)
IPVC 2020 workshops focuse on the theme, “Science and Education for Action Against HPV.” They provide state-of-the-art knowledge on all papillomavirus (PV)-related topics, from basic science to global health impact.
Workshops are run by and have speakers who are worldwide leaders in the field. They provide a unique forum for education and discussion, for the full spectrum of professional audiences – junior through senior researchers; basic scientists, clinicians and public health investigators.
At IPVC 2020, the pre-conference workshops are made up of interdisciplinary workshops, consisting of a series of talks covering key aspects of basic science, clinical and public health, and workshops covering each of the three tracks – basic science, clinical or public health-global impact – where specific topics of contemporary interest are covered. A particular emphasis is given to controversial areas of research and on experiences across different populations.
Although workshops stand alone as an educational and scientific activity, they are designed to provide the necessary scientific background to follow the main conference, where the latest knowledge in research will be presented. For junior scientists, the workshops help them to be educated on both the basics and cutting-edge knowledge of papillomavirus biology, epidemiology and prevention and control of papillomavirus infection and disease.
IPVC 2020 workshops are a unique way to connect across the fields, and attendees will enjoy PV research from different perspectives and participate in wider scientific discussions.
Interdisciplinary
- Papillomavirus Biology
- Burden of Disease
- Detection and Screening
- Vaccination
Specialisation
Basic Science
- HPV Viral Entry, Replication and Trafficking
- HPV Genera and Associated Diseases
- New Technologies
Clinical
- Cervix: Screening and Management
- Screening and Management in Non-cervical Disease
- Communication Skills
Public Health
- HPV Vaccine
- Screening / Treatment
- Communication Issues in Optimizing HPV Prevention Strategies
The International Papillomavirus Society and Eurogin are pleased to hold Maurice Hilleman Award Ceremony at the IPVC 2020 Conference.
The Maurice Hilleman award honors the memory of Maurice Hilleman, PhD, one of the most effective vaccinologists in history. Dr. Maurice Hilleman led Merck MSD’s Department of Virus and Cell Biology from 1956 to 1984. Of the fourteen vaccines routinely recommended in current vaccine schedules, he developed eight, including measles, mumps, hepatitis A, hepatitis B, chickenpox, meningitis, pneumonia and Haemophilus influenzae bacteria.
A committee comprised of members of the IPVS Board and the Eurogin Scientific Committee selected the winner from among the submitted nominations.
We are delighted to announce that the 2020 Maurice Hilleman Award was given to to Dr. Laura Koutsky, MSPH, PhD in recognition of her outstanding contribution to HPV research and for the breakthrough results she achieved as principal investigator in the very first proof-of principle HPV-16 VLP vaccine trials.
Dr. Koutsky will deliver a keynote lecture at a dedicated ceremony on Wednesday July 22nd 16:00 CET.
For more details, review the full IPVC 2020 program.
